Australia markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9300-0.1200 (-3.93%)
At close: 04:00PM EDT
2.8200 -0.11 (-3.75%)
After hours: 06:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 41.03M
Enterprise value 34.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)15.63
Price/book (mrq)2.00
Enterprise value/revenue 22.93
Enterprise value/EBITDA -0.24

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3-33.26%
S&P500 52-week change 326.36%
52-week high 35.1000
52-week low 32.0800
50-day moving average 32.8261
200-day moving average 33.0986

Share statistics

Avg vol (3-month) 362.57k
Avg vol (10-day) 329.49k
Shares outstanding 513.36M
Implied shares outstanding 613.36M
Float 83.56M
% held by insiders 112.80%
% held by institutions 152.73%
Shares short (30 Apr 2024) 4374.16k
Short ratio (30 Apr 2024) 42.57
Short % of float (30 Apr 2024) 42.84%
Short % of shares outstanding (30 Apr 2024) 42.80%
Shares short (prior month 28 Mar 2024) 4179.14k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 325 July 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,610.83%

Management effectiveness

Return on assets (ttm)-15.91%
Return on equity (ttm)-76.26%

Income statement

Revenue (ttm)1.5M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)14.60%
Gross profit (ttm)N/A
EBITDA -20.59M
Net income avi to common (ttm)-25.8M
Diluted EPS (ttm)-3.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.43M
Total cash per share (mrq)1.14
Total debt (mrq)2.87M
Total debt/equity (mrq)11.21%
Current ratio (mrq)1.49
Book value per share (mrq)2.48

Cash flow statement

Operating cash flow (ttm)-23.32M
Levered free cash flow (ttm)-6.9M